Vet Busted: DEA Denies Drug Registration Over State Oversight
Published Date: 9/11/2025
Notice
Summary
Chanelle D. Remien, a veterinarian from Washington, tried to get a DEA registration to handle controlled substances but was denied because she currently lacks state permission. She didn’t ask for a hearing, so the denial stands. This means she can’t legally handle these substances, and the decision is final with no extra costs or deadlines for her.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
DEA Denies Registration in Washington
The Drug Enforcement Administration denied the pending application for Certificate of Registration No. W17076337C for Chanelle D. Remien, DVM, because she is not licensed to practice veterinary medicine in Washington. The denial is effective October 14, 2025, and the Order also denies any other pending application of Chanelle D. Remien for registration in Washington. As a result, she may not legally handle controlled substances in Washington.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20226, By Grace Inc. Counseling Services; Decision and Order
By Grace Inc. Counseling Services in Baltimore faced losing its DEA license because it didn’t keep good records and lied about its owner’s past drug conviction. After a hearing, the DEA decided to revoke their registration, meaning they can’t legally handle controlled substances anymore. This affects the clinic’s ability to operate and could impact patients relying on their services.
2026-20227, St. Michael's Pharmacy; Decision and Order
St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.
Previous / Next Documents
Previous: 2025-17484, Notice of Final Federal Agency Actions on Proposed Transportation Project in Utah
Utah’s transportation team just gave the green light to upgrade roads around Kimball Junction! They’re adding extra lanes on SR-224 and improving intersections to make driving and biking smoother and safer. These changes will help everyone get around faster and easier, with work set to move forward soon.
Next: 2025-17489, Notice of Inventory Completion: South Dakota State Historical Society Archaeological Research Center, Rapid City, SD, and U.S. Army Corps of Engineers, Omaha District, Omaha, NE
The South Dakota State Historical Society Archaeological Research Center and the U.S. Army Corps of Engineers finished checking old human remains and found they belong to Native American tribes. This means these remains will be returned to the right tribes, respecting their heritage. No money changes hands, but the tribes involved should get ready for the next steps soon.